Scilex, a listed company, plans to sell shares in its holding subsidiary for $200 million worth of Bitcoin.

Scilex Holding Company (NASDAQ: SCLX), an innovative revenue-generating company, announced that it has signed a Securities Purchase Agreement ("SPA") with an institutional investor to exchange $200 million worth of common stock of its majority-owned subsidiary, Semnur Pharmaceuticals, Inc., for $200 million worth of Bitcoin. Under the SPA, the institutional investor will purchase 12,500,000 shares of Semnur common stock held by Scilex at a price of $16 per share. Closing is expected to occur on or about September 23, 2025.